PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

philips vereos pet/ct systems rsna 2013 molecular nuclear imaging
Technology | December 13, 2013

December 13, 2013 — Philips unveiled the Vereos PET/CT fully digital p...

cyclone 70 zevacor IBM nuclear imaging radiopharmaceuticals and tracers PET
News | November 08, 2013
November 8, 2013 — Zevacor Molecular, a healthcare firm that manufactures and distributes...
News | October 22, 2013

October 22, 2013 – Nuclear Imaging Services LLC (NIS) has completed the first U.S.-based ECAT Scintron installation...

remote viewing system rsna 2013 claron nil universal viewer nilread
Technology | October 07, 2013

October 7, 2013 — Claron Technology will announce extended modality support for its Nil universal zero-footprint...

Feature | July 29, 2013

July 29, 2013 — GE Healthcare has initiated a Class I recall of most of its SPECT nuclear imaging systems and called...

Feature | July 26, 2013 | Jamshid Maddahi, M.D., FACC, FASNC, and René R. S. Packard, M.D.
Coronary artery disease (CAD) is a major cause of death in modern industrialized countries. Assessments of regional...
This is a BFPET PET nuclear cardiac imaging scan for myocardial perfusion, nuclear cardiology

BFPET demonstrates higher resolution in the evaluation of myocardial perfusion in this series of images contrasting the results of a PET scan done with FluoroPharma's fluorine-18 based agent and a SPECT study done with sestamibi. Images were captured during an investigator-initiated study of BFPET conducted at 301 Hospital in Beijing, China.

Feature | Nuclear Imaging | July 23, 2013 | Dave Fornell

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (...

News | June 19, 2013

June 19, 2013 — Coronary artery disease (CAD) is one of the world’s most prevalent and silent killers....

News | June 13, 2013

June 13, 2013 — Mirada Medical collaborators presentnew...

MIM Encore

Technology | June 13, 2013

June 13, 2013 —  MIM Software Inc. has introduced a new version of MIM Encore that provides a single platform for...

Technology | June 11, 2013

June 11, 2013 — Siemens Healthcare has introduced Biograph mCT Flow, a...

Feature | June 11, 2013

June 10, 2013 – Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR)...

Technology | May 17, 2013

May 17, 2013 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Medical Imaging Electronics (...

CardioPET

Dynamic scanning images illustrate potential image quality of fatty acid uptake using PET/CT with FluoroPharma's CardioPET.

Feature | May 14, 2013 | Thijs Spoor

The next generation of positron emission tomography (PET) imaging agents will herald an age when PET will eclipse...

LEU TechneLite generator
Feature | March 06, 2013

As the U.S. government works to strengthen its global nuclear security strategy by eliminating potential sources of...

Overlay Init